|
|
Endocrine disrupting chemicals (EDCs) have been associated with negative impacts on human health, including cancers and altered reproductive function, as well as numerous adverse environmental impacts. They are currently regulated by the European Union through REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals). While legislative criteria to identify EDCs in biocides and pesticides has recently been established, current testing tools do not always appropriately identify effects, particularly those related to certain less studied or newly developed EDCs. ERGO aims to improve identification and hazard assessment of EDCs for the protection of human health and the environment. It will do so by breaking down the wall that currently exists between the different research fields that investigate adverse effects of EDCs in different vertebrate classes. |
TITLE: |
ERGO |
PROGRAMME: |
Horizon2020 |
TYPE OF ACTION: |
Research and Innovation Action (RIA) |
TOTAL BUDGET: DURATION: |
€6.9 million January 2019 – December 2023 (60 Months) |
CONSORTIUM: |
15 partners from eight countries |
COORDINATOR: |
Syddansk Universitet (SDU) Denmark |
OBJECTIVES
AQUATT'S ROLE
|
For more information on this initiative, visit: www.ergo-project.eu Funded by the European Union Horizon2020 Programme |